Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer Article

Industry Collaboration International Collaboration

cited authors

  • Socinski, MA; Sandler, AB; Miller, LL; Locker, PK; Hanover, CK; Elfring, GL; Israel, VK; Pirotta, N; Natale, RB

Publication Date

  • February 15, 2001

webpage

published in

category

start page

  • 1078

end page

  • 1087

volume

  • 19

issue

  • 4